biotech / news / / CNBC
Bristol Myers Squibb will offer Eliquis, its blockbuster blood thinner and top-prescribed product, for free to Medicaid.
Nine major drugmakers agreed to lower U.S. drug prices in exchange for tariff exemptions and investment pledges.
KEY POINTS
- Bristol Myers Squibb will provide its top-selling blood thinner Eliquis for free to Medicaid patients.
- The companies must sell drugs to Medicaid at lowest 'most favored nation' prices and guarantee that for new medicines.
- Merck and Sanofi will offer up to 70% discounts on selected drugs via direct-to-consumer programs like TrumpRx.
- Full deal terms remain undisclosed, making the actual scope and impact of these agreements uncertain.
COMPANIES
Summarized by Newsio from CNBC. How we summarize →